ArticlePsychiatry and clinical psychopharmacology2021
Validation of Chinese Version of Positive and Negative Syndrome Scale-6 in Clinical Setting: A Preliminary Study.
Article in Psychiatry and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Application of PANSS-6 in the assessment of severity and improvement in patients with schizophrenia: a clinical antipsychotic trial of effectiveness.BMC psychiatry · 2025Trial
- Gaming Disorder in First Episode Psychosis: Prevalence and Impact on Symptomatology and Functioning in a Prospective Cohort Study.Schizophrenia bulletin · 2026Article
- A study on the reliability and validity of CWS in Chinese schizophrenia patients.BMC psychiatry · 2025Article
- Exploration of the associations between violent and aggressive behaviors risk and NHHR, TyG in patients with schizophrenia: an SHAP interpretable machine learning prediction and FAERS pharmacovigilance analysis.Lipids in health and disease · 2025Article
- How to assess response.European archives of psychiatry and clinical neuroscience · 2025Article
- Relationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study.BMC psychiatry · 2025Article
- COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).EClinicalMedicine · 2025Article
- Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits.BMC psychiatry · 2024Article
- The association between symptomatic remission and social support in community-dwelling schizophrenia patients during COVID-19.Frontiers in psychiatry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Positive and Negative Syndrome Scale-6 (PANSS-6) is a brief measure to assess the core symptoms of schizophrenia. Psychometric characteristics of PANSS-6 in clinical settings are to be determined. We conducted this study among Chinese inpatients of schizophrenia in clinical settings, to determine psychometric characteristics of PANSS-6, and its' accuracy for identifying antipsychotic efficacy. Methods: Two hundred sixteen inpatients of schizophrenia were interviewed at baseline, week 4 and week 8 by experienced psychiatrists to collect information for rating PANSS-30 and PANSS-6. Internal consistency was estimated by the Cronbach's α; criterion validity was determined by Spearman's correlations between sum scores of PANSS-6 and PANSS-30; factorial validity was determined by confirmatory factor analysis (CFA); the sensitivity, specificity, positive predictive value (PPV); and negative predictive value (NPV) of PANSS-6 for identifying responders and remitters were calculated. Results: The Cronbach's α coefficients of PANSS-6 were 0.72 (95% CI: 0.66-0.78) at baseline. Sum scores of PANSS-6 were significantly correlated with that of PANSS-30. Confirmatory factor analysis confirmed this 2-factor model fit well: χ Conclusion: Positive and Negative Syndrome Scale-6 is a sound scale for measuring psychotic severity and monitoring treatment outcomes of schizophrenia in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.